1 Result

People

  1. Bromberg
    Bromberg
  2. Caravelli
    Caravelli
  3. Dang
    Dang
  4. Gucalp
    Gucalp
  5. Hudis
    Hudis
  6. Massague
    Massague
  7. Merced
    Merced
  8. Norton
    Norton
  9. Patil
    Patil
  10. Santamauro
    Santamauro

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  2. Biostatistics Service (1)
  3. Breast Medicine Service (1)
  4. Cancer Biology and Genetics Program Faculty (1)
  5. Center for Pancreatic Cancer Research (1)
  6. Department of Medicine (1)
  7. Division of Subspecialty Medicine (1)
  8. Epidemiology and Biostatistics (1)
  9. GSK Faculty (1)
  10. Pulmonary (1)
  1. "Jean Santamauro"
  2. "Chau Dang"
Formats
  1. Journal Article (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  2. Biostatistics Service (1)
  3. Breast Medicine Service (1)
  4. Cancer Biology and Genetics Program Faculty (1)
  5. Center for Pancreatic Cancer Research (1)
  6. Department of Medicine (1)

More Groups

People
  1. Alyson Merced (1)
  2. Ayca Gucalp (1)
  3. Chau Dang (1)
  4. Clifford Hudis (1)
  5. Jacqueline Bromberg (1)
  6. James Caravelli (1)

More People

Years
  1. 2011 (1)
Publications
  1. Clinical Breast Cancer (1)
Publishers
  1. Elsevier Inc. (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
    Clinical Breast Cancer (2011)

    Fulltext@MSK | Save